Intrasense (ALINS) - Total Assets
Based on the latest financial reports, Intrasense (ALINS) holds total assets worth €7.99 Million EUR (≈ $9.35 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ALINS net assets for net asset value and shareholders' equity analysis.
Intrasense - Total Assets Trend (2008–2025)
This chart illustrates how Intrasense's total assets have evolved over time, based on quarterly financial data.
Intrasense - Asset Composition Analysis
Current Asset Composition (December 2025)
Intrasense's total assets of €7.99 Million consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.0% |
| Accounts Receivable | €1.63 Million | 20.4% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €5.32 Million | 66.5% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Intrasense's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Intrasense.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Intrasense's current assets represent 30.5% of total assets in 2025, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 10.0% of total assets in 2025, up from 1.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 66.0% of total assets, an increase from 7.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 66.5% of total assets.
Intrasense Competitors by Total Assets
Key competitors of Intrasense based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Pharmx Technologies Ltd
AU:PHX
|
Australia | AU$18.82 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
Australia | AU$1.64 Million |
|
Global Health Ltd
AU:GLH
|
Australia | AU$2.84 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$664.83K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
Intrasense - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 0.48 | 2.14 |
| Quick Ratio | 1.26 | 0.48 | 2.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €509.99K | €-2.59 Million | €2.27 Million |
Intrasense - Advanced Valuation Insights
This section examines the relationship between Intrasense's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.52 |
| Latest Market Cap to Assets Ratio | 1.26 |
| Asset Growth Rate (YoY) | 4.0% |
| Total Assets | €7.99 Million |
| Market Capitalization | $10.11 Million USD |
Valuation Analysis
Above Book Valuation: The market values Intrasense's assets above their book value (1.26x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Intrasense's assets grew by 4.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Intrasense (2008–2025)
The table below shows the annual total assets of Intrasense from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €7.99 Million ≈ $9.35 Million |
+4.03% |
| 2024-12-31 | €7.68 Million ≈ $8.98 Million |
-26.50% |
| 2023-12-31 | €10.45 Million ≈ $12.22 Million |
+60.61% |
| 2022-12-31 | €6.51 Million ≈ $7.61 Million |
-25.78% |
| 2021-12-31 | €8.77 Million ≈ $10.25 Million |
+37.85% |
| 2020-12-31 | €6.36 Million ≈ $7.44 Million |
+51.26% |
| 2019-12-31 | €4.21 Million ≈ $4.92 Million |
-4.48% |
| 2018-12-31 | €4.40 Million ≈ $5.15 Million |
+20.28% |
| 2017-12-31 | €3.66 Million ≈ $4.28 Million |
-30.90% |
| 2016-12-31 | €5.30 Million ≈ $6.19 Million |
-13.89% |
| 2015-12-31 | €6.15 Million ≈ $7.19 Million |
-10.25% |
| 2014-12-31 | €6.85 Million ≈ $8.01 Million |
-10.94% |
| 2013-12-31 | €7.70 Million ≈ $9.00 Million |
-18.49% |
| 2012-12-31 | €9.44 Million ≈ $11.04 Million |
+51.60% |
| 2011-12-31 | €6.23 Million ≈ $7.28 Million |
+24.24% |
| 2010-12-31 | €5.01 Million ≈ $5.86 Million |
-8.95% |
| 2009-12-31 | €5.51 Million ≈ $6.44 Million |
-4.54% |
| 2008-12-31 | €5.77 Million ≈ $6.74 Million |
-- |
About Intrasense
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more